TP53 and hematologic disorder: Increased KMD2B expression could facilitate the proliferation of hematopoietic progenitor cells and induced leukemic transformation according to a previous study [29], and the TP53 gene is a well-recognized prognostic predictor in several hematological malignancies [30].